VALN Valneva SE

26.1
-0.15  -1%
Previous Close 26.25
Open 25.58
52 Week Low 24.1573
52 Week High 31.33
Market Cap $1,302,097,236
Shares 49,888,783
Float 49,888,783
Enterprise Value $1,178,891,335
Volume 6,568
Av. Daily Volume 27,820
Stock charts supplied by TradingView

Upcoming Catalysts

Drug Stage Catalyst Date
VLA1553
Chikungunya Virus Infection
Phase 3
Phase 3
Premium membership is required to view catalyst dates, analyst ratings, earnings dates and cash burn data. Click here to unlock and sign up to a 14-day FREE TRIAL.

Drug Pipeline

Drug Stage Notes
VLA2001-301 + alum and CpG 1018
COVID-19 vaccine
Phase 1/2
Phase 1/2
Phase 3 trial initiation announced April 21, 2021.
VLA15
Lyme disease vaccine
Phase 2
Phase 2
Phase 2 trial ongoing. Phase 3 trial to commence 3Q 2022.